Holen Sie sich die Stockscreener-App
0.4754
0.08%
0.0004
Handel nachbörslich:
.48
0.0046
+0.97%
Schlusskurs vom Vortag:
$0.475
Offen:
$0.4788
24-Stunden-Volumen:
20,124
Relative Volume:
0.07
Marktkapitalisierung:
$1.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.86M
KGV:
-0.1896
EPS:
-2.5071
Netto-Cashflow:
$-2.57M
1W Leistung:
-4.15%
1M Leistung:
-13.63%
6M Leistung:
-61.66%
1J Leistung:
-81.36%
1-Tages-Spanne:
$0.466
$0.4811
1-Wochen-Bereich:
$0.466
$0.4963
52-Wochen-Spanne:
$0.428
$2.79
Bone Biologics Corp Stock (BBLG) Company Profile
Firmenname
Bone Biologics Corp
Sektor
Branche
Telefon
(781) 552-4452
Adresse
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.4754 | 1.37M | 0 | -2.86M | -2.57M | -2.5071 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 127.93B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Bone Biologics Corp Aktie (BBLG) Neueste Nachrichten
Form 4 Bone Biologics Corp For: 1 October By Investing.com - Investing.com Nigeria
114K options with a $0.50 exercise price go to Bone Biologics (BBLG) director Bruce Stroever. - Stock Titan
Form 8K Bone Biologics Corp For: 29 September By Investing.com - Investing.com Nigeria
Bone Biologics shareholders approve board nominees and reverse stock split - Investing.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
BBLG Q2 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Developer Misses EstimateDividend Cut Risk - careplusvn.com
Bone Biologics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Bone Biologics (BBLG) faces Nasdaq $1 deadline and eyes reverse split - Stock Titan
Bone Biologics Corp Warrants (BBLGW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bone Biologics expands Australian trial to six hospital sites - Investing.com Australia
Bone Biologics expands Australian trial to six hospital sites By Investing.com - Investing.com UK
Six Australian hospitals agree to join Bone Biologics' bone-graft trial - Stock Titan
Bone Biologics Corp (BBLG) Holds Flat at $0.56 Within Tight Trading RangeStrangle Setup - dars.gov.et
BBLGW 8-K FilingsBone Biologics Corp Warrants SEC 8-K - Stock Titan
Bone Biologics Corp Warrants (BBLGW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
A company developing bone products will meet investors in New York - Stock Titan
Bone Biologics (NASDAQ: BBLGW) Schedules Six Key Proposals for September 28 Shareholder Vote - Kalkine Media
Bone Biologics Corp Warrants (BBLGW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Bone Biologics Corp Warrants (BBLGW) Peer Comparison – Compare with Others - Value Research
Orthobiologics Market Report Examines Leading Companies And Growth Opportunities - openPR.com
Bone Biologics (NASDAQ:BSPK): What Could Its Scheduled Update Reveal? - kalkinemedia.com
Bone (BBLG): Finishes 3.47% Higher at $0.63 in Latest Trading; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance for the Current SessionETF Outflow Streak - vinanet.vn
Bone (BBLGW): Shows Minimal Net Change at $8.24 in Latest Trading; Chart Watch: the Supplied Trading Band Runs From $7.83 to $8.65 under the Current SnapshotPut Flow Alert - siam.in
Bone (BBLG) Chart: Finishes 3.47% Lower at $0.62 for the Current Session; the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotVolume Climax - vinanet.vn
Bone (BBLG) Results and Estimates: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Post-Report Move: The Stock Ends Down 2.58% in the Latest SessionEPS Growth Report - vinanet.vn
Bone Biologics (NASDAQ: BBLG) seeks 1-for-2 to 1-for-10 reverse split approval - Stock Titan
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLGW - TradingView
Number of shareholders of Bone Biologics Corp – NASDAQ:BBLGW - tradingview.com
BBLG Efficiency Improves as Crucial Trials Advance - Yahoo Finance
Bone Biologics Corp (BBLG) Slips 2.86% as Shares Test Key Support at $0.63Systematic Flow - vinanet.vn
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Volatility Breakout Picks - vinanet.vn
Bone Biologics Raises $2.7M, Extends Cash Runway to Q2 2027 - Minichart
Bone Biologics Warrants (BBLGW) Hold at $3.50 as Traders Eye Tight RangeEquity Put Call - dars.gov.et
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Bone Biologics Corporation Achieves 32-Month Validated Shelf Life For rhNELL-1 - marketscreener.com
Bone Biologics Corp expected to post a loss of 39 cents a shareEarnings Preview - TradingView
BBLG Q1 2026 Earnings: Narrower-Than-Expected Loss of -$0.43, Though Shares Slip 5.67%Weak Earnings Momentum - dars.gov.et
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
US: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m - Investors in Healthcare
Bone Biologics Warrants (BBLGW) Steady at $8.0 as Tight Trading Range Takes ShapeBreakout Confirmation - careplusvn.com
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone - Orthopedics This Week
Isto Biologics Acquires NovaBone | Press Release - ACCESS Newswire
Bone Biologics Warrants (BBLGW) Hold Flat at $8.00 as Range-Bound Trading PersistsMA Cross Alert - dars.gov.et
Bone Biologics (BBLG) Dips 3.23% to $0.85 — Shares Approach Key Support at $0.81Factor Rotation - careplusvn.com
Bone Biologics Corp Warrants (BBLGW) Hold Steady at $8.0 Amid Low Volume ConsolidationPre-Earnings Momentum - careplusvn.com
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp Warrants (BBLGW) Holds Steady at $8.0 as Consolidation Pattern EmergesMESA MA - po-news-eg.net
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp SEC Filing (Jul 27, 2026) - Stock Titan
Finanzdaten der Bone Biologics Corp-Aktie (BBLG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):